Drug-eluting Stents Perform Well In An Emergency, NEJM Study Shows
This article was originally published in The Pink Sheet Daily
Executive Summary
AMI long-term outcomes were better than with bare-metal option in the Mass. study, but a national registry would provide long-term safety data for more patient types.
You may also be interested in...
In An Emergency, Value Of Drug-Eluting Stents Still Questionable, Docs Say
More data is needed before drug-eluting stents should be considered for routine use as part of emergency treatment for a heart attack, according to an editorial in the Sept. 14 New England Journal of Medicine
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?